ArticlePaediatric drugs2024

Adverse Event Profile of First-line Drugs for Treating Patent Ductus Arteriosus in Neonates: A Disproportionality Analysis Study of USFDA Adverse Event Reporting System.

Kannan Sridharan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.